PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 54 citations in OpenAlex.

1. Gallium-Containing Agents for Tumor Diagnosis and Therapy: Current Status and Future Prospects.Small (Weinheim an der Bergstrasse, Germany) · 2026
   Review
2. Diagnostic role of endoscopic ultrasonography in defining the clinical features and histopathological spectrum of gastroenteropancreatic neuroendocrine tumors.World journal of gastrointestinal endoscopy · 2025
   Article
3. Nuclear Imaging Modalities in the Diagnosis and Management of Thyroid Cancer.Current molecular medicine · 2024
   Review
4. A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.Journal of clinical medicine · 2023
   Review
5. Diagnostic and prognostic value ofArchives of medical science : AMS · 2023
   Article
6. Long-term outcome of indigenousThe British journal of radiology · 2021
   Observational
7. Intrapancreatic accessory spleen mimicking malignant tumor: three case reports.Acta radiologica open · 2019
   Article
8. Pharmacokinetics of protein and peptide conjugates.Drug metabolism and pharmacokinetics · 2019
   Review
9. Cushing Syndrome Secondary to Primary Neuroendocrine Lung Carcinoma.Case reports in endocrinology · 2019
   Article
10. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?Korean journal of radiology · 2019
    Review
11. Case - Bladder paraganglioma in a pediatric patient.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
12. Imitators of chronic pancreatitis: diffuse neuroendocrine tumour of the pancreas.BJR case reports · 2017
    Article
13. Evolving management of insulinoma: Experience at a tertiary care centre.The Indian journal of medical research · 2016
    Article
14. Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?World journal of clinical oncology · 2016
    Article
15. Comparison of Diagnostic Sensitivity and Quantitative Indices Between (68)Ga-DOTATOC PET/CT and (111)In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report.Nuclear medicine and molecular imaging · 2015
    Article
16. Role of Ga-68 DOTANOC Positron Emission Tomography/ Computed Tomography Scan in Clinical Management of Patients with Neuroendocrine Tumors and its Correlation with Conventional Imaging- Experience in a Tertiary Care Center in India.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
17. Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review.World journal of nuclear medicine
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as